tusnel pediatric- dextromethorphan, guiafenesin, pseudoephedrine hcl liquid
llorens pharmaceutical international division - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - purpose cough suppressant expectorant nasal decongestant ask a doctor before use if your child has - heart disease - high blood pressure - thyroid disease - diabetes - a cough that occurs with too much phlegm (mucus) - a persistent or chronic cough such as occurs with asthma when using this product - do not exceed recommended dosage stop use and ask a doctor if - nervousness, dizziness or sleeplessness occurs - symptoms do not get better within 7 days or accompanied by fever - cough last more than 7 days, comes back, or is accompanied by fever, rash or persistent headache. a persistent cough could be a sign of a serious condition. uses - helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive - temporarily relieves these symptoms occurring with a cold: nasal congestions, cough due to minor throat and bronchial irritation.
rutacid tablets chewable
krka d.d. - hydrotalcite - tablets chewable - 500mg
ambien cr- zolpidem tartrate tablet, coated
sanofi-aventis u.s. llc - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - zolpidem tartrate 6.25 mg - ambien cr (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset). the clinical trials performed in support of efficacy were up to 3 weeks (using polysomnography measurement up to 2 weeks in both adult and elderly patients) and 24 weeks (using patient-reported assessment in adult patients only) in duration [see clinical studies (14)] . ambien cr is contraindicated in patients - who have experienced complex sleep behaviors after taking ambien cr [see warnings and precautions (5.1)]. - with known hypersensitivity to zolpidem. observed reactions include anaphylaxis and angioedema [see warnings and precautions (5.4)]. risk summary neonates born to mothers using zolpidem late in the third trimester of pregnancy have been reported to experience symptoms of respiratory depression and sedation [see clinical considerations and data] . published data on the use
gazim x
cts chemical industries ltd, israel - simethicone - tablets - simethicone 125 mg - combinations of complexes of aluminium, calcium and magnesium compound - antiflatulence.
simicol tablets
cts chemical industries ltd, israel - simethicone - tablets - simethicone 125 mg - combinations of complexes of aluminium, calcium and magnesium compound - antiflatulence.
rennie dual action chewable tablets calcium carbonate 625mg magnesium carbonate 73.5mg alginic acid 150mg
bayer limited - alginic acid; calcium carbonate; magnesium carbonate - chewable tablet - 625/73.5/150 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds
rennie
alphafarma limited - calcium carbonate 680 mg, magnesium carbonate, heavy 80 mg - chewable tablet
allucid plus suspension syrup
biodeal laboratories ltd p.o. box 32040 nairoki kenya - magnesium hydroxide aluminium hydroxide and - syrup - magnesium hydroxide b.p. 195mg aluminium - combinations and complexes of aluminium calcium
alugel oral suspension
elys chemical industries ltd po box 40411-oo100 nairobi - aluminium hydroxide bp magnesium trisilicate bp - oral suspension - 120 mg/ 250 mg/ per 5ml - combinations and complexes of aluminium calcium
maalox suspension oral suspension
sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - magnesium hydroxide 200mg + dried aluminium - oral suspension - magnesium hydroxide 200mg + aluminium hydroxide - combinations and complexes of aluminium calcium